Harvard Bioscience, Inc. Forecast, price target & analysts
Harvard Bioscience, Inc. Target price 2024 - Analyst rating & recommendation
Harvard Bioscience, Inc. Classifications & Recommendation:
Harvard Bioscience, Inc. Target price
| Target price | $6.92 |
| Course | $2.85 |
| Price potential |
142.69%
register free of charge
|
| Number of estimates | 3 |
|
3 Analysts have issued a price target Harvard Bioscience, Inc. 2025 .
The average Harvard Bioscience, Inc. target price is $6.92.
This is
142.69%
register free of charge
$7.00
145.61%
register free of charge
$6.75
136.84%
register free of charge
|
|
| A rating was issued by 3 analysts: 3 Analysts recommend Harvard Bioscience, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the Harvard Bioscience, Inc. share has an average upside potential 2025 of
142.69%
register free of charge
|
Sales and margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 112.25 | 113.50 |
| 0.96% | 1.11% | |
| EBITDA margin | 8.27% | 10.70% |
| 234.65% | 29.43% | |
| Net margin | -3.09% | -1.91% |
| 64.88% | 38.28% |
3 Analysts have issued a sales forecast Harvard Bioscience, Inc. 2024 . The average Harvard Bioscience, Inc. sales estimate is
This results in the following potential growth figures:
2 Analysts have issued an Harvard Bioscience, Inc. EBITDA forecast 2024. The average Harvard Bioscience, Inc. EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
3 Harvard Bioscience, Inc. Analysts have issued a net profit forecast 2024. The average Harvard Bioscience, Inc. net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -0.08 | -0.05 |
| 65.22% | 37.50% | |
| P/E ratio | negative | |
| EV/Sales | 1.42 |
3 Analysts have issued a Harvard Bioscience, Inc. forecast for earnings per share. The average Harvard Bioscience, Inc. <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the Harvard Bioscience, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Harvard Bioscience, Inc....
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
